HUT73419A - Process for preparing [1,2,4]triazolo[4,3-a]quinoxaline derivatives and pharmaceutical compositions containing them - Google Patents
Process for preparing [1,2,4]triazolo[4,3-a]quinoxaline derivatives and pharmaceutical compositions containing them Download PDFInfo
- Publication number
- HUT73419A HUT73419A HU9502726A HU9502726A HUT73419A HU T73419 A HUT73419 A HU T73419A HU 9502726 A HU9502726 A HU 9502726A HU 9502726 A HU9502726 A HU 9502726A HU T73419 A HUT73419 A HU T73419A
- Authority
- HU
- Hungary
- Prior art keywords
- triazolo
- preparing
- pharmaceutical compositions
- compositions containing
- quinoxaline derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK93310A DK31093D0 (OSRAM) | 1993-03-19 | 1993-03-19 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HU9502726D0 HU9502726D0 (en) | 1995-11-28 |
| HUT73419A true HUT73419A (en) | 1996-07-29 |
Family
ID=8092112
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9502726A HUT73419A (en) | 1993-03-19 | 1994-02-25 | Process for preparing [1,2,4]triazolo[4,3-a]quinoxaline derivatives and pharmaceutical compositions containing them |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5559106A (OSRAM) |
| EP (1) | EP0691969A1 (OSRAM) |
| JP (1) | JPH08507536A (OSRAM) |
| KR (1) | KR100313051B1 (OSRAM) |
| CN (1) | CN1041930C (OSRAM) |
| AU (1) | AU685783B2 (OSRAM) |
| CA (1) | CA2158545A1 (OSRAM) |
| DK (1) | DK31093D0 (OSRAM) |
| FI (1) | FI954386A7 (OSRAM) |
| HU (1) | HUT73419A (OSRAM) |
| IL (1) | IL108800A (OSRAM) |
| NO (1) | NO305286B1 (OSRAM) |
| NZ (1) | NZ262365A (OSRAM) |
| TW (1) | TW304195B (OSRAM) |
| WO (1) | WO1994021639A1 (OSRAM) |
| ZA (1) | ZA941926B (OSRAM) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4314592A1 (de) * | 1993-04-28 | 1994-11-03 | Schering Ag | Benzo(f)chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln |
| ATE183186T1 (de) * | 1994-09-16 | 1999-08-15 | Novo Nordisk As | (1,2,4>-triazolo(4,3-a>chinoxalinon-derivate, ihre herstellung und verwendung |
| NZ292107A (en) * | 1994-09-16 | 1999-02-25 | Novo Nordisk As | [1,2,4]triazolo[4,3-a]quinoxalinone derivatives and medicaments |
| US5679680A (en) * | 1995-02-16 | 1997-10-21 | Warner-Lambert Company | α-substituted hydrazides having calpain inhibitory activity |
| FR2743363A1 (fr) * | 1996-01-10 | 1997-07-11 | Rhone Poulenc Rorer Sa | 5h,10h-imidazo(1,2-a)indeno(1,2-e)pyrazine-a-ones substituees en position 2, leur preparation et les medicaments les contenant |
| IL125950A0 (en) * | 1997-09-05 | 1999-04-11 | Pfizer Prod Inc | Methods of administering ampa receptor antagonists to treat dyskinesias associated with dopamine agonist therapy |
| CN1285834A (zh) | 1997-11-11 | 2001-02-28 | 小野药品工业株式会社 | 稠合吡嗪化合物 |
| AU2298399A (en) * | 1998-02-06 | 1999-08-23 | Yoshitomi Pharmaceutical Industries, Ltd. | Novel azapeptide type hydroxamic acid derivatives |
| US20040152694A1 (en) * | 2003-02-04 | 2004-08-05 | Istvan Kurucz | Methods and compositions for treating inflammatory disorders of the airways |
| ES2599054T3 (es) * | 2006-12-13 | 2017-01-31 | Aska Pharmaceutical Co., Ltd. | Derivados de quinoxalina |
| CN102341399A (zh) | 2009-03-05 | 2012-02-01 | 安斯泰来制药株式会社 | 喹喔啉化合物 |
| EP2338492A1 (en) | 2009-12-24 | 2011-06-29 | Universidad del Pais Vasco | Methods and compositions for the treatment of alzheimer |
| WO2012033101A1 (ja) * | 2010-09-07 | 2012-03-15 | アステラス製薬株式会社 | キノキサリン化合物 |
| ES2575092T3 (es) | 2011-06-27 | 2016-06-24 | Janssen Pharmaceutica, N.V. | Derivados de 1-aril-4-metil-[1,2,4]triazolo[4,3-a]quinoxalina |
| RU2657540C2 (ru) | 2012-06-26 | 2018-06-14 | Янссен Фармацевтика Нв | Комбинации, содержащие ингибиторы pde 2, такие как 1-арил-4-метил-[1,2,4]триазоло[4,3-а]хиноксалиновые соединения, и ингибиторы pde 10, для применения в лечении неврологических или метаболических расстройств |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4354027A (en) * | 1980-05-19 | 1982-10-12 | Usv Pharmaceutical Corporation | Triazoloquinoxalin-4-ones |
| US4547501A (en) * | 1983-09-02 | 1985-10-15 | Pfizer Inc. | Method of using [1,2,4]triazolo[4,3-a]quinoxaline-4-amine derivatives as antidepressant and antifatigue agents |
| US5153196A (en) * | 1991-06-05 | 1992-10-06 | Eli Lilly And Company | Excitatory amino acid receptor antagonists and methods for the use thereof |
| WO1993020077A1 (fr) * | 1992-04-03 | 1993-10-14 | Yamanouchi Pharmaceutical Co., Ltd. | Derive de quinoxalinone fondue et composition pharmaceutique le contenant |
-
1993
- 1993-03-19 DK DK93310A patent/DK31093D0/da not_active Application Discontinuation
-
1994
- 1994-02-25 WO PCT/DK1994/000077 patent/WO1994021639A1/en not_active Ceased
- 1994-02-25 KR KR1019950703970A patent/KR100313051B1/ko not_active Expired - Fee Related
- 1994-02-25 CN CN94191979A patent/CN1041930C/zh not_active Expired - Fee Related
- 1994-02-25 CA CA002158545A patent/CA2158545A1/en not_active Abandoned
- 1994-02-25 HU HU9502726A patent/HUT73419A/hu unknown
- 1994-02-25 EP EP94908979A patent/EP0691969A1/en not_active Withdrawn
- 1994-02-25 AU AU62018/94A patent/AU685783B2/en not_active Ceased
- 1994-02-25 NZ NZ262365A patent/NZ262365A/en unknown
- 1994-02-25 FI FI954386A patent/FI954386A7/fi unknown
- 1994-02-25 JP JP6520538A patent/JPH08507536A/ja active Pending
- 1994-02-28 TW TW083101703A patent/TW304195B/zh active
- 1994-03-01 IL IL108800A patent/IL108800A/en active IP Right Grant
- 1994-03-18 ZA ZA941926A patent/ZA941926B/xx unknown
- 1994-12-07 US US08/350,744 patent/US5559106A/en not_active Expired - Fee Related
-
1995
- 1995-09-18 NO NO953673A patent/NO305286B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| KR960701057A (ko) | 1996-02-24 |
| IL108800A (en) | 1998-02-22 |
| US5559106A (en) | 1996-09-24 |
| EP0691969A1 (en) | 1996-01-17 |
| NZ262365A (en) | 1997-05-26 |
| NO305286B1 (no) | 1999-05-03 |
| DK31093D0 (OSRAM) | 1993-03-19 |
| AU685783B2 (en) | 1998-01-29 |
| JPH08507536A (ja) | 1996-08-13 |
| ZA941926B (en) | 1995-09-18 |
| TW304195B (OSRAM) | 1997-05-01 |
| CN1041930C (zh) | 1999-02-03 |
| AU6201894A (en) | 1994-10-11 |
| FI954386A0 (fi) | 1995-09-18 |
| IL108800A0 (en) | 1994-06-24 |
| CN1122601A (zh) | 1996-05-15 |
| CA2158545A1 (en) | 1994-09-29 |
| HU9502726D0 (en) | 1995-11-28 |
| NO953673L (no) | 1995-11-17 |
| NO953673D0 (no) | 1995-09-18 |
| FI954386L (fi) | 1995-09-18 |
| WO1994021639A1 (en) | 1994-09-29 |
| FI954386A7 (fi) | 1995-09-18 |
| KR100313051B1 (ko) | 2002-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUT73419A (en) | Process for preparing [1,2,4]triazolo[4,3-a]quinoxaline derivatives and pharmaceutical compositions containing them | |
| JP2004500347A5 (OSRAM) | ||
| NZ336629A (en) | Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of mip-1-alpha binding to its ccr1 receptor | |
| JP2002502874A5 (OSRAM) | ||
| HUP0203514A2 (hu) | Kinuklidin vegyületek és ezeket tartalmazó gyógyszerkészítmények és eljárás a vegyületek előállítására | |
| CA2290918A1 (en) | Heteroaromatic bicyclic derivatives useful as anticancer agents | |
| EP1243583A4 (en) | HETEROCYCLIC COMPOUNDS WITH SULFONAMIDE GROUPS | |
| HUP0100615A2 (hu) | Szubsztituált 2-(2,6-dioxo-3-fluoro-piperidin-3-il)-izoindolinok és ezek alkalmazása TNFalfa-szint csökkentésére | |
| AU8136482A (en) | Dihydropyridine anti-ischaemic and antihypertensive agents | |
| IL145923A0 (en) | Tri-aryl acid derivatives as ppar receptor ligands | |
| JP2002513793A5 (OSRAM) | ||
| RU93004675A (ru) | 1,2,4-оксадиазолил-феноксиалкилизоксазолы, их применение в качестве противовирусных агентов, фармацевтическая композиция | |
| CA2431952A1 (en) | Muscarinic antagonists | |
| IE830687L (en) | Cephalosporin derivatives | |
| CA2088742A1 (en) | Benzimidazole and imidazopyridine derivatives and their application | |
| HUP0100184A2 (hu) | Szubsztituált 2-(benzil-amino)-2-fenil-acetamid-vegyületek és ezeket tartalmazó gyógyszerkészítmények | |
| ZA200203305B (en) | Benzothiadiazine derivatives, preparation method and pharmaceutical compositions containing same. | |
| CA2220188A1 (en) | Vinylpyrrolidinon cephalosporin derivatives | |
| EP0268990A3 (en) | New benzothiadiazine compounds, processes for the preparation thereof and pharmaceutical composition comprising the same | |
| CA2467973A1 (en) | Pyridine derivatives as nmda receptor ligands | |
| JPH1087577A5 (OSRAM) | ||
| EP0288962A3 (en) | Aryl-aralkyl ethers, processes for their preparation and pharmaceutical composition comprising them | |
| EP0383256A3 (en) | A novel substituted-acetamide compound and a process for the preparation thereof | |
| DE69330601D1 (de) | Serotoninergische ergolin derivate | |
| IL108970A0 (en) | Substituted (arylalkylaminobenzyl) aminopropionamide derivatives, their preparation and pharmaceutical compositions containing them |